The role of leptin in the control of insulin-glucose axis

Frontiers in Neuroscience

Volumn , Issue 7 APR, 2013, Pages

  Amitani, Marie ^a   Asakawa, Akihiro ^a   Amitani, Haruka ^a   Inui, Akio ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Adipo insulin axis; Food intake; Leptin; Leptin gene therapy

Indexed keywords

GLUCOSE; INSULIN; JANUS KINASE; LEPTIN; STAT PROTEIN;

APPETITE; ARTICLE; DIABETES MELLITUS; FEEDING BEHAVIOR; GENE THERAPY; GLUCOSE METABOLISM; HUMAN; LIVER; NERVE CELL PLASTICITY; NONHUMAN; OBESITY; SYNAPSE; TISSUES;

EID: 84878854783     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2013.00051     Document Type: Article

References (146)

1. Ahima, R. S., Prabakaran, D., and Flier, J. S. (1998). Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function. J. Clin. Invest. 101, 1020-1027.
2. Ahima, R. S., Saper, C. B., Flier, J. S., and Elmquist, J. K. (2000). Leptin regulation of neuroendocrine systems. Front. Neuroendocrinol. 21, 263-307. doi: 10.1006/frne.2000.0197
3. Akiyama, T., Tachibana, I., Shirohara, H., Watanabe, N., and Otsuki, M. (1996). High-fat hypercaloric diet induces obesity, glucose intolerance and hyperlipidemia in normal adult male Wistar rat. Diabetes Res. Clin. Pract. 31, 27-35.
4. Asakawa, A., Inui, A., Inui, T., Katsuura, G., Fujino, M. A., and Kasuga, M. (2003). Leptin treatment ameliorates anxiety in ob/ob obese mice. J. Diabetes Complicat. 17, 105-107.
5. Asakawa, A., Inui, A., Ueno, N., Makino, S., Fujino, M. A., and Kasuga, M. (1999). Urocortin reduces food intake and gastric emptying in lean and ob/ob obese mice. Gastroenterology 116, 1287-1292.
6. Attig, L., Solomon, G., Ferezou, J., Abdennebi-Najar, L., Taouis, M., Gertler, A., et al. (2008). Early postnatal leptin blockage leads to a long-term leptin resistance and susceptibility to diet-induced obesity in rats. Int. J. Obes. (Lond.) 32, 1153-1160.
7. Bagnasco, M., Dube, M. G., Kalra, P. S., and Kalra, S. P. (2002). Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy. Endocrinology 143, 4409-4421.
8. Bagnasco, M., Dube, M. G., Katz, A., Kalra, P. S., and Kalra, S. P. (2003). Leptin expression in hypothalamic PVN reverses dietary obesity and hyperinsulinemia but stimulates ghrelin. Obes. Res. 11, 1463-1470.
9. Baicy, K., London, E. D., Monterosso, J., Wong, M. L., Delibasi, T., Sharma, A., et al. (2007). Leptin replacement alters brain response to food cues in genetically leptin-deficient adults. Proc. Natl. Acad. Sci. U.S.A. 104, 18276-18279.
10. Banks, W. A., Dipalma, C. R., and Farrell, C. L. (1999). Impaired transport of leptin across the blood-brain barrier in obesity. Peptides 20, 1341-1345.
11. Banks, W. A., Farr, S. A., and Morley, J. E. (2006). The effects of high fat diets on the blood-brain barrier transport of leptin: failure or adaptation? Physiol. Behav. 88, 244-248.
12. Banks, W. A., and Farrell, C. L. (2003). Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible. Am. J. Physiol. Endocrinol. Metab. 285, E10-E15.
13. Banks, W. A., Niehoff, M. L., Martin, D., and Farrell, C. L. (2002). Leptin transport across the blood-brain barrier of the Koletsky rat is not mediated by a product of the leptin receptor gene. Brain Res. 950, 130-136.
14. Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., et al. (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342.
15. Bouret, S. G., Draper, S. J., and Simerly, R. B. (2004). Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 304, 108-110.
16. Bouret, S. G., and Simerly, R. B. (2004). Minireview: leptin and development of hypothalamic feeding circuits. Endocrinology 145, 2621-2626.
17. Brennan, A. M., Lee, J. H., Tsiodras, S., Chan, J. L., Doweiko, J., Chimienti, S. N., et al. (2009). r-metHuLeptin improves highly active antiretroviral therapy-induced lipoatrophy and the metabolic syndrome, but not through altering circulating IGF and IGF-binding protein levels: observational and interventional studies in humans. Eur. J. Endocrinol. 160, 173-176.
18. Buettner, R., Newgard, C. B., Rhodes, C. J., and O'Doherty, R. M. (2000). Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia. Am. J. Physiol. Endocrinol. Metab. 278, E563-E569.
19. Burguera, B., Couce, M. E., Curran, G. L., Jensen, M. D., Lloyd, R. V., Cleary, M. P., et al. (2000). Obesity is associated with a decreased leptin transport across the blood-brain barrier in rats. Diabetes 49, 1219-1223.
20. Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R., and Burn, P. (1995). Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 546-549.
21. Canto, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., et al. (2009). AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 458, 1056-1060.
22. Chen, G., Koyama, K., Yuan, X., Lee, Y., Zhou, Y. T., O'Doherty, R., et al. (1996). Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc. Natl. Acad. Sci. U.S.A. 93, 14795-14799.
23. Chinookoswong, N., Wang, J. L., and Shi, Z. Q. (1999). Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes 48, 1487-1492.
24. Cohen, P., Zhao, C., Cai, X., Montez, J. M., Rohani, S. C., Feinstein, P., et al. (2001). Selective deletion of leptin receptor in neurons leads to obesity. J. Clin. Invest. 108, 1113-1121.
25. Coppari, R., Ichinose, M., Lee, C. E., Pullen, A. E., Kenny, C. D., McGovern, R. A., et al. (2005). The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity. Cell Metab. 1, 63-72.
26. Cowley, M. A., Smith, R. G., Diano, S., Tschop, M., Pronchuk, N., Grove, K. L., et al. (2003). The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37, 649-661.
27. Delahaye, F., Breton, C., Risold, P. Y., Enache, M., Dutriez-Casteloot, I., Laborie, C., et al. (2008). Maternal perinatal undernutrition drastically reduces postnatal leptin surge and affects the development of arcuate nucleus proopiomelanocortin neurons in neonatal male rat pups. Endocrinology 149, 470-475.
28. Denroche, H. C., Levi, J., Wideman, R. D., Sequeira, R. M., Huynh, F. K., Covey, S. D., et al. (2011). Leptin therapy reverses hyperglycemia in mice with streptozotocin-induced diabetes, independent of hepatic leptin signaling. Diabetes 60, 1414-1423.
29. Dhillon, H., Kalra, S. P., and Kalra, P. S. (2001a). Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus. Mol. Ther. 4, 139-145.
30. Dhillon, H., Kalra, S. P., Prima, V., Zolotukhin, S., Scarpace, P. J., Moldawer, L. L., et al. (2001b). Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: a long-term study. Regul. Pept. 99, 69-77.
31. Dhillon, S. S., McFadden, S. A., Chalmers, J. A., Centeno, M. L., Kim, G. L., and Belsham, D. D. (2011). Cellular leptin resistance impairs the leptin-mediated suppression of neuropeptide Y secretion in hypothalamic neurons. Endocrinology 152, 4138-4147.
32. Dube, M. G., Beretta, E., Dhillon, H., Ueno, N., Kalra, P. S., and Kalra, S. P. (2002). Central leptin gene therapy blocks high-fat diet-induced weight gain, hyperleptinemia, and hyperinsulinemia: increase in serum ghrelin levels. Diabetes 51, 1729-1736.
33. Ebihara, K., Masuzaki, H., and Nakao, K. (2004). Long-term leptin-replacement therapy for lipoatrophic diabetes. N. Engl. J. Med. 351, 615-616.
34. Elias, C. F., Aschkenasi, C., Lee, C., Kelly, J., Ahima, R. S., Bjorbaek, C., et al. (1999). Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 23, 775-786.
35. Elmquist, J. K., Bjorbaek, C., Ahima, R. S., Flier, J. S., and Saper, C. B. (1998). Distributions of leptin receptor mRNA isoforms in the rat brain. J. Comp. Neurol. 395, 535-547.
36. Elmquist, J. K., Elias, C. F., and Saper, C. B. (1999). From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22, 221-232.
37. Farmer, S. R. (2009). Obesity: be cool, lose weight. Nature 458, 839-840.
38. Farooqi, I. S., Bullmore, E., Keogh, J., Gillard, J., O'Rahilly, S., and Fletcher, P. C. (2007). Leptin regulates striatal regions and human eating behavior. Science 317, 1355.
39. Farooqi, I. S., Jebb, S. A., Langmack, G., Lawrence, E., Cheetham, C. H., Prentice, A. M., et al. (1999). Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med. 341, 879-884.
40. Farooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., et al. (2002). Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest. 110, 1093-1103.
41. Fei, H., Okano, H. J., Li, C., Lee, G. H., Zhao, C., Darnell, R., et al. (1997). Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc. Natl. Acad. Sci. U.S.A. 94, 7001-7005.
42. Field, A. E., Coakley, E. H., Must, A., Spadano, J. L., Laird, N., Dietz, W. H., et al. (2001). Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch. Intern. Med. 161, 1581-1586.
43. Fruhbeck, G. (2006). Intracellular signalling pathways activated by leptin. Biochem. J. 393, 7-20.
44. Fujikawa, T., Chuang, J. C., Sakata, I., Ramadori, G., and Coppari, R. (2010). Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice. Proc. Natl. Acad. Sci. U.S.A. 107, 17391-17396.
45. Fujimiya, M., Ataka, K., Asakawa, A., Chen, C. Y., Kato, I., and Inui, A. (2012). Regulation of gastroduodenal motility: acyl ghrelin, des-acyl ghrelin and obestatin and hypothalamic peptides. Digestion 85, 90-94.
46. Gautron, L., and Elmquist, J. K. (2011). Sixteen years and counting: an update on leptin in energy balance. J. Clin. Invest. 121, 2087-2093.
47. George, S., Rochford, J. J., Wolfrum, C., Gray, S. L., Schinner, S., Wilson, J. C., et al. (2004). A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 304, 1325-1328.
48. German, J., Kim, F., Schwartz, G. J., Havel, P. J., Rhodes, C. J., Schwartz, M. W., et al. (2009). Hypothalamic leptin signaling regulates hepatic insulin sensitivity via a neurocircuit involving the vagus nerve. Endocrinology 150, 4502-4511.
49. German, J. P., Thaler, J. P., Wisse, B. E., Oh, I. S., Sarruf, D. A., Matsen, M. E., et al. (2011). Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia. Endocrinology 152, 394-404.
50. German, J. P., Wisse, B. E., Thaler, J. P., Oh, I. S., Sarruf, D. A., Ogimoto, K., et al. (2010). Leptin deficiency causes insulin resistance induced by uncontrolled diabetes. Diabetes 59, 1626-1634.
51. Granado, M., Fuente-Martin, E., Garcia-Caceres, C., Argente, J., and Chowen, J. A. (2012). Leptin in early life: a key factor for the development of the adult metabolic profile. Obes. Facts 5, 138-150.
52. Granado, M., Garcia-Caceres, C., Fuente-Martin, E., Diaz, F., Mela, V., Viveros, M. P., et al. (2011). Effects of acute changes in neonatal leptin levels on food intake and long-term metabolic profiles in rats. Endocrinology 152, 4116-4126.
53. Grillo, C. A., Piroli, G. G., Evans, A. N., Macht, V. A., Wilson, S. P., Scott, K. A., et al. (2011a). Obesity/hyperleptinemic phenotype adversely affects hippocampal plasticity: effects of dietary restriction. Physiol. Behav. 104, 235-241.
54. Grillo, C. A., Piroli, G. G., Junor, L., Wilson, S. P., Mott, D. D., Wilson, M. A., et al. (2011b). Obesity/hyperleptinemic phenotype impairs structural and functional plasticity in the rat hippocampus. Physiol. Behav. 105, 138-144.
55. Gunawardana, S. C., and Piston, D. W. (2012). Reversal of type 1 diabetes in mice by brown adipose tissue transplant. Diabetes 61, 674-682.
56. Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., et al. (1995). Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543-546.
57. Hileman, S. M., Pierroz, D. D., Masuzaki, H., Bjorbaek, C., El-Haschimi, K., Banks, W. A., et al. (2002). Characterizaton of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology 143, 775-783.
58. Huo, L., Gamber, K., Greeley, S., Silva, J., Huntoon, N., Leng, X. H., et al. (2009). Leptin-dependent control of glucose balance and locomotor activity by POMC neurons. Cell Metab. 9, 537-547.
59. Inoue, H., Ogawa, W., Asakawa, A., Okamoto, Y., Nishizawa, A., Matsumoto, M., et al. (2006). Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab. 3, 267-275.
60. Inui, A., Asakawa, A., Bowers, C. Y., Mantovani, G., Laviano, A., Meguid, M. M., et al. (2004). Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J. 18, 439-456.
61. Johnston, J. M., Greco, S. J., Hamzelou, A., Ashford, J. W., and Tezapsidis, N. (2011). Repositioning leptin as a therapy for Alzheimer's disease. Therapy 8, 481-490.
62. Julien, S. G., Dube, N., Hardy, S., and Tremblay, M. L. (2011). Inside the human cancer tyrosine phosphatome. Nat. Rev. Cancer 11, 35-49.
63. Kalra, S. P. (2009). Central leptin gene therapy ameliorates diabetes type 1 and 2 through two independent hypothalamic relays; a benefit beyond weight and appetite regulation. Peptides 30, 1957-1963.
64. Kalra, S. P. (2011). Pivotal role of leptin-hypothalamus signaling in the etiology of diabetes uncovered by gene therapy: a new therapeutic intervention? Gene Ther. 18, 319-325.
65. Kalra, S. P., and Kalra, P. S. (2005). Gene-transfer technology: a preventive neurotherapy to curb obesity, ameliorate metabolic syndrome and extend life expectancy. Trends Pharmacol. Sci. 26, 488-495.
66. Kamohara, S., Burcelin, R., Halaas, J. L., Friedman, J. M., and Charron, M. J. (1997). Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389, 374-377.
67. Kastin, A. J., and Pan, W. (2006). Intranasal leptin: blood-brain barrier bypass (BBBB) for obesity? Endocrinology 147, 2086-2087.
68. Kirk, S. L., Samuelsson, A. M., Argenton, M., Dhonye, H., Kalamatianos, T., Poston, L., et al. (2009). Maternal obesity induced by diet in rats permanently influences central processes regulating food intake in offspring. PLoS ONE 4:e5870. doi: 10.1371/journal.pone.0005870
69. Kitamura, T., Feng, Y., Kitamura, Y. I., Chua, S. C. Jr., Xu, A. W., Barsh, G. S., et al. (2006). Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat. Med. 12, 534-540.
70. Kojima, S., Asakawa, A., Amitani, H., Sakoguchi, T., Ueno, N., Inui, A., et al. (2009). Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice. Peptides 30, 962-966.
71. Koyama, K., Shimabukuro, M., Chen, G., Wang, M. Y., Lee, Y., Kalra, P. S., et al. (1998). Resistance to adenovirally induced hyperleptinemia in rats. Comparison of ventromedial hypothalamic lesions and mutated leptin receptors. J. Clin. Invest. 102, 728-733.
72. Kuehnen, P., Laubner, K., Raile, K., Schofl, C., Jakob, F., Pilz, I., et al. (2011). Protein phosphatase 1 (PP-1)-dependent inhibition of insulin secretion by leptin in INS-1 pancreatic beta-cells and human pancreatic islets. Endocrinology 152, 1800-1808.
73. Lam, D. D., Leinninger, G. M., Louis, G. W., Garfield, A. S., Marston, O. J., Leshan, R. L., et al. (2011). Leptin does not directly affect CNS serotonin neurons to influence appetite. Cell Metab. 13, 584-591.
74. Lam, D. D., Przydzial, M. J., Ridley, S. H., Yeo, G. S., Rochford, J. J., O'Rahilly, S., et al. (2008). Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptors. Endocrinology 149, 1323-1328.
75. Laubner, K., Kieffer, T. J., Lam, N. T., Niu, X., Jakob, F., and Seufert, J. (2005). Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic beta-cells. Diabetes 54, 3410-3417.
76. Lee, J. H., Chan, J. L., Sourlas, E., Raptopoulos, V., and Mantzoros, C. S. (2006). Recombinant methionyl human leptin therapy in replacement doses improves insulin resistance and metabolic profile in patients with lipoatrophy and metabolic syndrome induced by the highly active antiretroviral therapy. J. Clin. Endocrinol. Metab. 91, 2605-2611.
77. Lee, Y., Naseem, R. H., Duplomb, L., Park, B. H., Garry, D. J., Richardson, J. A., et al. (2004). Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 101, 13624-13629.
78. Levi, J., Gray, S. L., Speck, M., Huynh, F. K., Babich, S. L., Gibson, W. T., et al. (2011). Acute disruption of leptin signaling in vivo leads to increased insulin levels and insulin resistance. Endocrinology 152, 3385-3395.
79. Licinio, J., Caglayan, S., Ozata, M., Yildiz, B. O., De Miranda, P. B., O'Kirwan, F., et al. (2004). Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc. Natl. Acad. Sci. U.S.A. 101, 4531-4536.
80. Licinio, J., Milane, M., Thakur, S., Whelan, F., Yildiz, B. O., Delibasi, T., et al. (2007a). Effects of leptin on intake of specific micro- and macro-nutrients in a woman with leptin gene deficiency studied off and on leptin at stable body weight. Appetite 49, 594-599.
81. Licinio, J., Ribeiro, L., Busnello, J. V., Delibasi, T., Thakur, S., Elashoff, R. M., et al. (2007b). Effects of leptin replacement on macro- and micronutrient preferences. Int. J. Obes. (Lond.) 31, 1859-1863.
82. London, E. D., Berman, S. M., Chakrapani, S., Delibasi, T., Monterosso, J., Erol, H. K., et al. (2011). Short-term plasticity of gray matter associated with leptin deficiency and replacement. J. Clin. Endocrinol. Metab. 96, E1212-E1220.
83. Lu, X. Y. (2007). The leptin hypothesis of depression: a potential link between mood disorders and obesity? Curr. Opin. Pharmacol. 7, 648-652.
84. Mantzoros, C. S., Magkos, F., Brinkoetter, M., Sienkiewicz, E., Dardeno, T. A., Kim, S. Y., et al. (2011). Leptin in human physiology and pathophysiology. Am. J. Physiol. Endocrinol. Metab. 301, E567-E584.
85. Marroqui, L., Gonzalez, A., Neco, P., Caballero-Garrido, E., Vieira, E., Ripoll, C., et al. (2012). Role of leptin in the pancreatic beta-cell: effects and signaling pathways. J. Mol. Endocrinol. 49, R9-R17.
86. Marston, O. J., Garfield, A. S., and Heisler, L. K. (2011). Role of central serotonin and melanocortin systems in the control of energy balance. Eur. J. Pharmacol. 660, 70-79.
87. Matochik, J. A., London, E. D., Yildiz, B. O., Ozata, M., Caglayan, S., Depaoli, A. M., et al. (2005). Effect of leptin replacement on brain structure in genetically leptin-deficient adults. J. Clin. Endocrinol. Metab. 90, 2851-2854.
88. Matsen, M. E., Thaler, J. P., Wisse, B. E., Guyenet, S. J., Meek, T. H., Ogimoto, K., et al. (2013). In uncontrolled diabetes, thyroid hormone and sympathetic activators induce thermogenesis without increasing glucose uptake in brown adipose tissue. Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.00488.2012. [Epub ahead of print].
89. McMinn, J. E., Liu, S. M., Liu, H., Dragatsis, I., Dietrich, P., Ludwig, T., et al. (2005). Neuronal deletion of Lepr elicits diabesity in mice without affecting cold tolerance or fertility. Am. J. Physiol. Endocrinol. Metab. 289, E403-E411.
90. Minokoshi, Y., Alquier, T., Furukawa, N., Kim, Y. B., Lee, A., Xue, B., et al. (2004). AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428, 569-574.
91. Mistry, A. M., Swick, A., and Romsos, D. R. (1999). Leptin alters metabolic rates before acquisition of its anorectic effect in developing neonatal mice. Am. J. Physiol. 277, R742-R747.
92. Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A., Rau, H., Wareham, N. J., et al. (1997). Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387, 903-908.
93. Moon, H. S., Matarese, G., Brennan, A. M., Chamberland, J. P., Liu, X., Fiorenza, C. G., et al. (2011). Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance. Diabetes 60, 1647-1656.
94. Morioka, T., Dishinger, J. F., Reid, K. R., Liew, C. W., Zhang, T., Inaba, M., et al. (2012). Enhanced GLP-1- and sulfonylurea-induced insulin secretion in islets lacking leptin signaling. Mol. Endocrinol. 26, 967-976.
95. Morsy, M. A., Gu, M. C., Zhao, J. Z., Holder, D. J., Rogers, I. T., Pouch, W. J., et al. (1998). Leptin gene therapy and daily protein administration: a comparative study in the ob/ob mouse. Gene Ther. 5, 8-18.
96. Morton, G. J., and Schwartz, M. W. (2011). Leptin and the central nervous system control of glucose metabolism. Physiol. Rev. 91, 389-411.
97. Mulligan, K., Khatami, H., Schwarz, J. M., Sakkas, G. K., Depaoli, A. M., Tai, V. W., et al. (2009). The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia. J. Clin. Endocrinol. Metab. 94, 1137-1144.
98. Must, A., Spadano, J., Coakley, E. H., Field, A. E., Colditz, G., and Dietz, W. H. (1999). The disease burden associated with overweight and obesity. JAMA 282, 1523-1529.
99. Muzzin, P., Cusin, I., Charnay, Y., and Rohner-Jeanrenaud, F. (2000). Single intracerebroventricular bolus injection of a recombinant adenovirus expressing leptin results in reduction of food intake and body weight in both lean and obese Zucker fa/fa rats. Regul. Pept. 92, 57-64.
100. Muzzin, P., Eisensmith, R. C., Copeland, K. C., and Woo, S. L. (1996). Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. Proc. Natl. Acad. Sci. U.S.A. 93, 14804-14808.
101. Naito, M., Fujikura, J., Ebihara, K., Miyanaga, F., Yokoi, H., Kusakabe, T., et al. (2011). Therapeutic impact of leptin on diabetes, diabetic complications, and longevity in insulin-deficient diabetic mice. Diabetes 60, 2265-2273.
102. Nakae, J., Cao, Y., Daitoku, H., Fukamizu, A., Ogawa, W., Yano, Y., et al. (2006). The LXXLL motif of murine forkhead transcription factor FoxO1 mediates Sirt1-dependent transcriptional activity. J. Clin. Invest. 116, 2473-2483.
103. Park, J. Y., Chong, A. Y., Cochran, E. K., Kleiner, D. E., Haller, M. J., Schatz, D. A., et al. (2008). Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy. J. Clin. Endocrinol. Metab. 93, 26-31.
104. Paz-Filho, G., Esposito, K., Hurwitz, B., Sharma, A., Dong, C., Andreev, V., et al. (2008a). Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients. Am. J. Physiol. Endocrinol. Metab. 295, E1401-E1408.
105. Paz-Filho, G. J., Babikian, T., Asarnow, R., Delibasi, T., Esposito, K., Erol, H. K., et al. (2008b). Leptin replacement improves cognitive development. PLoS ONE 3:e3098. doi: 10.1371/journal.pone.0003098
106. Paz-Filho, G., Wong, M. L., and Licinio, J. (2011). Ten years of leptin replacement therapy. Obes. Rev. 12, e315-e323.
107. Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., et al. (1995). Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269, 540-543.
108. Pinto, S., Roseberry, A. G., Liu, H., Diano, S., Shanabrough, M., Cai, X., et al. (2004). Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 304, 110-115.
109. Polesel, J., Zucchetto, A., Montella, M., Dal Maso, L., Crispo, A., La Vecchia, C., et al. (2009). The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann. Oncol. 20, 353-357.
110. Proulx, K., Richard, D., and Walker, C. D. (2002). Leptin regulates appetite-related neuropeptides in the hypothalamus of developing rats without affecting food intake. Endocrinology 143, 4683-4692.
111. Roberts, R. E., Deleger, S., Strawbridge, W. J., and Kaplan, G. A. (2003). Prospective association between obesity and depression: evidence from the Alameda County Study. Int. J. Obes. Relat. Metab. Disord. 27, 514-521.
112. Sasaki, T., Kim, H. J., Kobayashi, M., Kitamura, Y. I., Yokota-Hashimoto, H., Shiuchi, T., et al. (2010). Induction of hypothalamic Sirt1 leads to cessation of feeding via agouti-related peptide. Endocrinology 151, 2556-2566.
113. Schulz, C., Paulus, K., Johren, O., and Lehnert, H. (2012). Intranasal leptin reduces appetite and induces weight loss in rats with diet-induced obesity (DIO). Endocrinology 153, 143-153.
114. Schwartz, M. W., Baskin, D. G., Bukowski, T. R., Kuijper, J. L., Foster, D., Lasser, G., et al. (1996). Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45, 531-535.
115. Seufert, J. (2004). Leptin effects on pancreatic beta-cell gene expression and function. Diabetes 53(Suppl. 1), S152-S158.
116. Seufert, J., Kieffer, T. J., and Habener, J. F. (1999). Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc. Natl. Acad. Sci. U.S.A. 96, 674-679.
117. Shah, N., and Roux, F. (2009). The relationship of obesity and obstructive sleep apnea. Clin. Chest Med. 30, 455-465. vii.
118. Silva, J. P., Von Meyenn, F., Howell, J., Thorens, B., Wolfrum, C., and Stoffel, M. (2009). Regulation of adaptive behaviour during fasting by hypothalamic Foxa2. Nature 462, 646-650.
119. St-Pierre, J., and Tremblay, M. L. (2012). Modulation of leptin resistance by protein tyrosine phosphatases. Cell Metab. 15, 292-297.
120. Stark, R., Ashley, S. E., and Andrews, Z. B. (2013). AMPK and the neuroendocrine regulation of appetite and energy expenditure. Mol. Cell. Endocrinol. 366, 215-223.
121. Su, H., Jiang, L., Carter-Su, C., and Rui, L. (2012). Glucose enhances leptin signaling through modulation of AMPK activity. PLoS ONE 7:e31636. doi: 10.1371/journal.pone.0031636
122. Sullivan, P. W., Morrato, E. H., Ghushchyan, V., Wyatt, H. R., and Hill, J. O. (2005). Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care 28, 1599-1603.
123. Suzuki, M., Ding, Q., Muranaka, S., Kigure, M., Kojima, M., Terada, M., et al. (2008). Correlation between body weight (epididymal fat) and permeation rate of serum leptin through the blood-brain barrier (BBB) in male rats aged 8 months. Exp. Anim. 57, 485-488.
124. Toda, C., Shiuchi, T., Lee, S., Yamato-Esaki, M., Fujino, Y., Suzuki, A., et al. (2009). Distinct effects of leptin and a melanocortin receptor agonist injected into medial hypothalamic nuclei on glucose uptake in peripheral tissues. Diabetes 58, 2757-2765.
125. Toyoshima, Y., Gavrilova, O., Yakar, S., Jou, W., Pack, S., Asghar, Z., et al. (2005). Leptin improves insulin resistance and hyperglycemia in a mouse model of type 2 diabetes. Endocrinology 146, 4024-4035.
126. Ueno, N., Dube, M. G., Inui, A., Kalra, P. S., and Kalra, S. P. (2004). Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy. Endocrinology 145, 4176-4184.
127. Ueno, N., Inui, A., Kalra, P. S., and Kalra, S. P. (2006). Leptin transgene expression in the hypothalamus enforces euglycemia in diabetic, insulin-deficient nonobese Akita mice and leptin-deficient obese ob/ob mice. Peptides 27, 2332-2342.
128. Ushikai, M., Asakawa, A., Sakoguchi, T., Tanaka, C., and Inui, A. (2011). Centrally administered urocortin 3 inhibits food intake and gastric emptying in mice. Endocrine 39, 113-117.
129. Vatier, C., Gautier, J. F., and Vigouroux, C. (2012). Therapeutic use of recombinant methionyl human leptin. Biochimie 94, 2116-2125.
130. Wang, L., Liu, Y., Yan Lu, S., Nguyen, K. T., Schroer, S. A., Suzuki, A., et al. (2010a). Deletion of Pten in pancreatic ss-cells protects against deficient ss-cell mass and function in mouse models of type 2 diabetes. Diabetes 59, 3117-3126.
131. Wang, M. Y., Chen, L., Clark, G. O., Lee, Y., Stevens, R. D., Ilkayeva, O. R., et al. (2010b). Leptin therapy in insulin-deficient type I diabetes. Proc. Natl. Acad. Sci. U.S.A. 107, 4813-4819.
132. Wang, Y., Asakawa, A., Inui, A., and Kosai, K. (2010c). Leptin gene therapy in the fight against diabetes. Expert Opin. Biol. Ther. 10, 1405-1414.
133. Wauman, J., and Tavernier, J. (2011). Leptin receptor signaling: pathways to leptin resistance. Front. Biosci. 16, 2771-2793.
134. White, D. W., Zhou, J., Stricker-Krongrad, A., Ge, P., Morgenstern, J. P., Dembski, M., et al. (2000). Identification of leptin-induced transcripts in the mouse hypothalamus. Diabetes 49, 1443-1450.
135. Williams, K. W., Scott, M. M., and Elmquist, J. K. (2011). Modulation of the central melanocortin system by leptin, insulin, and serotonin: co-ordinated actions in a dispersed neuronal network. Eur. J. Pharmacol. 660, 2-12.
136. Williamson, D. A., Ravussin, E., Wong, M. L., Wagner, A., Dipaoli, A., Caglayan, S., et al. (2005). Microanalysis of eating behavior of three leptin deficient adults treated with leptin therapy. Appetite 45, 75-80.
137. Wolfrum, C., Besser, D., Luca, E., and Stoffel, M. (2003). Insulin regulates the activity of forkhead transcription factor Hnf-3beta/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization. Proc. Natl. Acad. Sci. U.S.A. 100, 11624-11629.
138. Xu, Y., Elmquist, J. K., and Fukuda, M. (2011). Central nervous control of energy and glucose balance: focus on the central melanocortin system. Ann. N.Y. Acad. Sci. 1243, 1-14.
139. Yamada, N., Katsuura, G., Ochi, Y., Ebihara, K., Kusakabe, T., Hosoda, K., et al. (2011). Impaired CNS leptin action is implicated in depression associated with obesity. Endocrinology 152, 2634-2643.
140. Yanovski, S. Z., and Yanovski, J. A. (2002). Obesity. N. Engl. J. Med. 346, 591-602.
141. Yaspelkis, B. B. 3rd., Davis, J. R., Saberi, M., Smith, T. L., Jazayeri, R., Singh, M., et al. (2001). Leptin administration improves skeletal muscle insulin responsiveness in diet-induced insulin-resistant rats. Am. J. Physiol. Endocrinol. Metab. 280, E130-E142.
142. Yu, X., Park, B. H., Wang, M. Y., Wang, Z. V., and Unger, R. H. (2008). Making insulin-deficient type 1 diabetic rodents thrive without insulin. Proc. Natl. Acad. Sci. U.S.A. 105, 14070-14075.
143. Zhang, S., Zhang, Q., Zhang, L., Li, C., and Jiang, H. (2012). Expression of ghrelin and leptin during the development of type 2 diabetes mellitus in a rat model. Mol. Med. Rep. doi: 10.3892/mmr.2012.1154. [Epub ahead of print].
144. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J. M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432.
145. Zhou, L., Sutton, G. M., Rochford, J. J., Semple, R. K., Lam, D. D., Oksanen, L. J., et al. (2007). Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metab. 6, 398-405.
146. Ziylan, Y. Z., Baltaci, A. K., and Mogulkoc, R. (2009). Leptin transport in the central nervous system. Cell Biochem. Funct. 27, 63-70.